| Primary |
| Hypertension |
34.3% |
| Cardiac Failure |
10.2% |
| Angina Pectoris |
7.3% |
| Glomerulonephritis Membranous |
7.3% |
| Coronary Arterial Stent Insertion |
5.8% |
| Hyperlipidaemia |
5.1% |
| Myocardial Infarction |
5.1% |
| Depressive Symptom |
2.9% |
| Gastric Ulcer Haemorrhage |
2.9% |
| Arthralgia |
2.2% |
| Gastric Ulcer |
2.2% |
| Gastrointestinal Haemorrhage |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Arteriogram |
1.5% |
| Cardiac Failure Congestive |
1.5% |
| Hypertonia |
1.5% |
| Irritability |
1.5% |
| Neurogenic Bladder |
1.5% |
| Prophylaxis |
1.5% |
| Sepsis |
1.5% |
|
| White Blood Cell Count Increased |
13.9% |
| Lymphocyte Stimulation Test Positive |
11.1% |
| Suicide Attempt |
11.1% |
| Pyrexia |
8.3% |
| No Adverse Effect |
5.6% |
| Renal Failure Chronic |
5.6% |
| Stridor |
5.6% |
| Urine Chloride Decreased |
5.6% |
| Angioedema |
2.8% |
| Complement Factor Increased |
2.8% |
| Diarrhoea |
2.8% |
| Drug Hypersensitivity |
2.8% |
| Drug-induced Liver Injury |
2.8% |
| Dysphagia |
2.8% |
| Eczema |
2.8% |
| Gastrointestinal Haemorrhage |
2.8% |
| Hepatic Function Abnormal |
2.8% |
| Hyperlipidaemia |
2.8% |
| Hypoglycaemia |
2.8% |
| Hypotension |
2.8% |
|
| Secondary |
| Hypertension |
30.1% |
| Cardiac Failure |
11.0% |
| Drug Use For Unknown Indication |
7.2% |
| Glomerulonephritis Membranous |
6.3% |
| Disseminated Tuberculosis |
4.7% |
| Acute Myocardial Infarction |
4.4% |
| Diabetes Mellitus |
4.4% |
| Coronary Arterial Stent Insertion |
4.2% |
| Thrombosis Prophylaxis |
4.0% |
| Hyperlipidaemia |
3.7% |
| Gastric Ulcer |
2.6% |
| Pneumonia |
2.6% |
| Cardiac Failure Congestive |
2.3% |
| Pruritus |
2.3% |
| Gastrointestinal Haemorrhage |
2.1% |
| Depressive Symptom |
1.9% |
| Myocardial Infarction |
1.6% |
| Polymyalgia Rheumatica |
1.6% |
| Angina Pectoris |
1.4% |
| Interstitial Lung Disease |
1.4% |
|
| Interstitial Lung Disease |
11.3% |
| Vomiting |
9.9% |
| Renal Impairment |
7.0% |
| Thrombocytopenia |
7.0% |
| White Blood Cell Count Decreased |
7.0% |
| Eosinophilic Pneumonia |
5.6% |
| Hypertensive Encephalopathy |
5.6% |
| Stevens-johnson Syndrome |
5.6% |
| Bradycardia |
4.2% |
| Hallucination, Visual |
4.2% |
| Pneumonia |
4.2% |
| Toxic Epidermal Necrolysis |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Blood Creatine Phosphokinase Increased |
2.8% |
| Blood Creatinine Increased |
2.8% |
| Eosinophil Count Increased |
2.8% |
| Hypotension |
2.8% |
| Medication Error |
2.8% |
| Rhinorrhoea |
2.8% |
| Shock |
2.8% |
|
| Concomitant |
| Hypertension |
30.9% |
| Cardiac Failure |
7.5% |
| Drug Use For Unknown Indication |
6.9% |
| Prophylaxis |
6.6% |
| Diabetes Mellitus |
5.9% |
| Insomnia |
3.8% |
| Constipation |
3.8% |
| Product Used For Unknown Indication |
3.6% |
| Atrial Fibrillation |
3.4% |
| Hyperlipidaemia |
3.1% |
| Hiv Infection |
3.1% |
| Chronic Hepatitis C |
2.7% |
| Cardiac Failure Chronic |
2.6% |
| Angina Pectoris |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Cardiac Failure Congestive |
2.4% |
| Gastritis |
2.4% |
| Heart Transplant |
2.4% |
| Pneumonia |
2.2% |
| Pulmonary Arterial Hypertension |
1.9% |
|
| Interstitial Lung Disease |
8.3% |
| Cardiac Failure |
7.3% |
| Pyrexia |
7.3% |
| Vomiting |
6.3% |
| Thrombocytopenia |
5.9% |
| Weight Increased |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Renal Impairment |
5.3% |
| Renal Failure Acute |
5.0% |
| White Blood Cell Count Increased |
5.0% |
| Hyperkalaemia |
4.6% |
| Cerebral Infarction |
4.3% |
| Platelet Count Decreased |
4.3% |
| Rhabdomyolysis |
4.3% |
| Urinary Tract Infection |
4.3% |
| Syncope |
3.6% |
| Hallucination |
3.3% |
| Pulmonary Infarction |
3.3% |
| Blood Creatine Phosphokinase Increased |
3.0% |
| Liver Disorder |
3.0% |
|
